Home \ Research \ Scientific publications \


Antibiotic use in the COVID-19 crisis in Spain

Investigation published in Clinical Microbiology and Infection

April 1st, 2021

Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was the world`s most pressing health crisis. The United Nations, the World Health Organization (WHO) and the European Center for Disease Control and Prevention have made antimicrobial resistance a top priority, establishing a task force in the G-20 and organizing a joint program initiative on antimicrobial resistance including countries from al over the world [1]. However, with the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus pandemic in January 2020, all efforts are now focused on COVID-19, including controlling infections and developing vaccines




Gonzalez-Zorn B.




See this article
Antibiotic use in the COVID-19 crisis in Spain

See it on NLM PubMed
Antibiotic use in the COVID-19 crisis in Spain



Participants:

Universidad ComplutenseServicio de Zoonosis de Transmisión Alimentaria y Resistencia a Antimicrobianos (ZTA). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).







Clinical Microbiology and Infection
FACTOR YEAR Q
8.067 2020

NLMID: 9516420

PMID: 33248926

ISSN: 1198-743X



TITLE: Antibiotic use in the COVID-19 crisis in Spain


JOURNAL: Clin. Microbiol. Infect.


NUMERACIÓN: 27(4):646-647


AÑO: 2021


PUBLISHER: Blackwell Scientific Publications


AUTHORS: Gonzalez-Zorn B.


VISAVET PARTICIPANTS


Bruno González Zorn

DOI: https://doi.org/10.1016/j.cmi.2020.09.055


CITE THIS PUBLICATION:

Gonzalez-Zorn B. Antibiotic use in the COVID-19 crisis in Spain. Clinical Microbiology and Infection. 27(4):646-647. 2021. (A). ISSN: 1198-743X. DOI: 10.1016/j.cmi.2020.09.055


UNITS: